Northern Trust
ROIV icon

Northern Trust’s Roivant Sciences ROIV Stock Holding History

Northern Trust’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133M Buy
3,762,157
+241,705
+7% +$7.14M 0.02% 658
2026
Q1 		$97.5M Buy
3,520,452
+234,524
+7% +$6.02M 0.01% 754
2025
Q4 		$71.3M Buy
3,285,928
+2,867
+0.1% +$56.6K 0.01% 910
2025
Q3 		$49.7M Buy
3,283,061
+49,847
+2% +$617K 0.01% 1135
2025
Q2 		$36.4M Sell
3,233,214
-68,085
-2% -$738K 0.01% 1289
2025
Q1 		$33.3M Sell
3,301,299
-146,783
-4% -$1.59M ﹤0.01% 1329
2024
Q4 		$40.8M Buy
3,448,082
+652,615
+23% +$7.72M 0.01% 1249
2024
Q3 		$32.3M Buy
2,795,467
+402,326
+17% +$4.58M 0.01% 1318
2024
Q2 		$25.3M Buy
2,393,141
+727,806
+44% +$7.98M ﹤0.01% 1409
2024
Q1 		$17.6M Buy
1,665,335
+185,791
+13% +$2M ﹤0.01% 1674
2023
Q4 		$16.6M Buy
1,479,544
+30,301
+2% +$295K ﹤0.01% 1745
2023
Q3 		$16.9M Buy
1,449,243
+565,049
+64% +$6.39M ﹤0.01% 1663
2023
Q2 		$8.91M Buy
884,194
+455,564
+106% +$4.07M ﹤0.01% 2144
2023
Q1 		$3.16M Buy
428,630
+30,915
+8% +$255K ﹤0.01% 2724
2022
Q4 		$3.18M Buy
397,715
+101,800
+34% +$566K ﹤0.01% 2750
2022
Q3 		$953K Buy
295,915
+29,805
+11% +$115K ﹤0.01% 3315
2022
Q2 		$1.08M Buy
266,110
+100,597
+61% +$399K ﹤0.01% 3326
2022
Q1 		$818K Sell
165,513
-2,831
-2% -$18.7K ﹤0.01% 3526
2021
Q4 		$1.7M Buy
+168,344
New +$1.4M ﹤0.01% 3306

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Northern Trust's ROIV Position: Q2 2026 in Review

Northern Trust increased its Roivant Sciences (ROIV) stake by 6.9% in Q2 2026, buying an estimated $7.14M and bringing the position to 3,762,157 shares worth $133M. The position accounts for 0.02% of the portfolio, ranked #658.

Northern Trust first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Northern Trust held 3,762,157 shares of Roivant Sciences worth $133M as of Q2 2026.
  • Northern Trust bought 241,705 Roivant Sciences shares in Q2 2026, an estimated $7.14M.
  • Roivant Sciences made up 0.02% of Northern Trust's portfolio in Q2 2026, its #658 holding.
  • Northern Trust first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.